Search results
Results from the WOW.Com Content Network
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.
Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna. [2]
In July 2018, the company opened a 200,000 square foot facility in Norwood, Massachusetts for manufacturing, preclinical and clinical work. [24] In December 2018, Moderna became a public company via the largest initial public offering of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share. [25 ...
Noubar Afeyan, chairman and co-founder of Moderna; $1.4 billion Seth Klarman , CEO and president of Baupost Group; $1.3 billion Paul Fireman , former chairman of Reebok; $1.3 billion
John Abele, co-founder of Boston Scientific, is Vermont's lone billionaire. He lives in Shelburne and a net worth of $1.9 billion, according to Forbes. He lives in Shelburne and a net worth of $1. ...
Net worth: $245B. 2. Jeff Bezos, Amazon and Blue Origin founder Net worth: $201B. 3. Bernard Arnault, LVMH founder and CEO Net worth: $197B. 4. Mark Zuckerberg, Meta cofounder and CEO Net worth ...
In 2014 Rossi retired from his functions at the board and as a scientific advisor at Moderna. [2] In 2015 Rossi was scientific co-founder of Intellia Therapeutics. In 2016 Rossi co-founded Magenta Therapeutics. Rossi was involved in the foundation of Stelexis Therapeutics, which develops new medication for treating cancerous stem cells.
As coronavirus cases across the nation continue to drop, 68 million doses of the vaccine have already been administered and an FDA panel just recommended the authorization of Johnson & Johnson’s ...